Circulating IL-6 levels among PAH patients can be a useful prognostic marker, as several studies have shown a strong inverse correlation between serum IL-6 levels and long-term survival outcomes [6,24]. This evidence concerns the gene IL6 and pulmonary arterial hypertension.